Milou Amber Hogervorst

6PUBLICATIONS
10CO-AUTHORS
Molecular targetsBiomedical imagingRisk policyDevelopment cooperationPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 10, 2025
Evolving Recommendations for Patient Populations Among Oncology Medicines: A Quantitative and Qualitative Analysis.

Milou A Hogervorst, Rick A Vreman, Theresa A Oduol

|Nov 05, 2024
Roadmap to Innovation of HTA Methods (IHTAM): insights from three case studies of quantitative methods.

Li Jiu, Junfeng Wang, Jan-Willem Versteeg

|Dec 18, 2023
Response to uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group - author's reply.

Milou Amber Hogervorst, Rick Vreman, Inkatuuli Heikkinen

|Aug 28, 2023
Perspectives on how to build bridges between regulation, health technology assessment and clinical guideline development: a qualitative focus group study with European experts.

Milou A Hogervorst, Mathias Møllebæk, Rick A Vreman

|Jun 16, 2023
Uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group.

Milou Amber Hogervorst, Rick Vreman, Inkatuuli Heikkinen

|Mar 01, 2023
Synergy between health technology assessments and clinical guidelines for multiple sclerosis.

Milou A Hogervorst, Rick A Vreman, Anna Zawada

Pageof 1

Frequent Collaborators

2 joint publications

Aukje Mantel-Teeuwisse

2 joint publications

Wim Goettsch

2 joint publications

Rick Vreman

2 joint publications

Inkatuuli Heikkinen